Blood cancers

Prognostic tool identifies relapsed DLBCL patients most likely to benefit from alloHCT

An international team of haematologists have developed a prognostic model that can identify diffuse large B-cell lymphoma patients who are most likely to benefit from an allogeneic transplant following a failed prior autologous haematopoietic cell transplant. Writing in the study published in the British Journal of Haematology the research team including Professor Mark Hertzberg from ...

Already a member?

Login to keep reading.

© 2021 the limbic